Chinese cancer drug developer Innovent Biologics, which has a number of PE backers, closed up on its Hong Kong trading debut, following a HK$3.3 billion ($421 million) IPO.
The company sold 215 million shares at HK$13.98 apiece, close to the top end of the indicative range. The stock closed up 18.6% on October 31 at HK$16.58. The offering was slightly oversubscribed,...
Cool Japan has taken a new angle on its cultural investment thesis with Spiber, a biotechnology developer bringing next-generation materials to the apparel industry
Creador has raised $50 million for its fourth Southeast Asia and India-focused private equity fund from the Asian Development Bank (ADB).
Everstone Group has established a partnership with Singapore-based warehouse operator GLP to invest $500 million in India’s logistics ecosystem.
Accel Partners and Qualcomm Ventures have joined an INR2.5 billion ($35 million) funding round for Indian agriculture industry platform operator Ninjacart.